Searched for
AFFORDABLE WEIGHT LOSS
Kiran Mazumdar-Shaw warns against long-term GLP-1 use, urges caution over weight-loss drugs, says 'for those who are not diabetic or clinically obese...'Nithin Kamath questions India's slow adoption of affordable GLP-1 weight-loss drugs, despite rising obesity. He points to challenges like l...- India’s GLP-1 boom loses steam as price war, weak retention hit generic weight-loss drug salesInitial excitement for India's generic weight-loss drugs is fading. Domestic manufacturers are lowering sales targets due to slower-than-ex...
- 'Cheaper than a gym, but still not selling': Nithin Kamath on why Indians aren't embracing popular weight-loss drugsDespite rising obesity and affordable generic GLP-1 drugs, India lags in adoption. Nithin Kamath highlights patient retention challenges wi...
- Stress, poor sleep and processed food are driving heart attacks in young Indians: Ramakanta PandaYoung Indian professionals, particularly in IT and finance, are facing a heart disease crisis due to unhealthy lifestyles. Leading cardiac ...
- Byju's Aakash endgame; Startup deal street wakes upHappy Monday! Byju's US lenders and Manipal are close to sealing a settlement over Aakash. This and more in today’s ETtech Morning Dispatch.
- FIFA World Cup 2026 Day 10: Germany, Sweden aim to retain top spots as stakes rise ahead of Round of 32; how to watch live streaming in US and Canada - check kick-off time and venuesMatchday 10 of the FIFA World Cup 2026 intensifies with crucial Group E and F fixtures. The Netherlands face a formidable Sweden, while Jap...
- Pizza Hut: From $600 loan to 20,000 stores and the new $2.7 billion twist for the global empirePizza Hut, a nearly 70-year-old American icon, has been split in a $2.7 billion deal. Yum Brands is selling its international business outs...
- Kiran Mazumdar-Shaw eyes crown of world’s top insulin supplier for BioconIndian drugmaker Biocon aims to be the world's top insulin supplier within five years, capitalising on growing demand as major pharmaceutic...
- The hidden cost of looking better: What health insurance covers, and what it leaves you to payRising demand for weight-loss drugs, cosmetic procedures and wellness treatments is creating a growing out-of-pocket healthcare expense cat...
- Alkem rolls out single-shot semaglutide syringes at Rs 350 for diabetes, weight lossAlkem Laboratories has launched semaglutide in single-shot pre-filled syringes in India. This makes treatment more accessible and affordabl...
- Time to take measured and logical risks? 5 small-caps from different sectors with upside potential of up to 26%Given the fluctuating situation in the Gulf region because of the US-Iran conflict, there is no guarantee that the market will not fall fur...
- Pine Labs shares rise over 4% after Q4 results. Why Morgan Stanley forecasts 67% upsidePine Labs shares surged after the company reported a significant turnaround, posting a Rs 59 crore net profit in Q4FY26 against a loss last...
- Forget 10,000 steps: Scientists say this specific daily number is all you actually need to stop weight from coming backWeight loss: A new study is challenging the popular “10,000 steps a day” rule, suggesting you may not need that much to protect your progre...
- SBI margins drag PSU banks, but private banks set for comeback: Pranav Gundlapalle, BernsteinState Bank of India's margin drop was a key event. Analysts suggest the worst may be over for banks. Private sector banks are expected to p...
- Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
- Why health freaks never skip these 5 moringa recipesMoringa recipes: Moringa, the "drumstick tree," is a global superfood trend, celebrated for its rich vitamins, minerals, and antioxidants. ...
- How to use chia seeds for weight loss: 10 ways to fuel your fitness journeyChia seeds are a popular and natural addition to many weight loss plans because of their high fibre and protein content, which can help kee...
- Why is the 2026 Social Security 2.8% COLA failing against 3.3% inflation? Is your retirement check shrinking?Social Security COLA 2026 Inflation Gap: Why 2.8% Increase Trails 3.3% Senior Inflation. The 2.8% Social Security COLA for 2026 is failing....
- Obesity drug market to gain as Indians pop the pill and Chinese bring moreIndia's obesity treatment market is set for a major shift by year-end. A wave of oral GLP1 weight-loss pills, including those from China, w...
- Popular US-based weight loss drug maker Eli Lilly plans to launch medicine in India next yearEli Lilly will launch Mounjaro in India in 2025. The drug treats type 2 diabetes and obesity. Lilly received marketing authorization in Jul...
Load More
